Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 4, 2007, Pages 892-898

  Röder, Esther ^a,b   Berger, Marjolein Y ^b   Hop, Wim C J ^c   Bernsen, Roos M D ^b   de Groot, Hans ^a   Gerth van Wijk, Roy ^a  

^a Section of Allergology   (Netherlands)

^b Department of General Practice ^*

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

adolescent; allergic rhinitis; child; grass pollen; Immunotherapy; primary care; sublingual

Indexed keywords

ANTHOXANTUM ODORATUM EXTRACT; DACTYLIS GLOMERATEIN EXTRACT; GRASS POLLEN EXTRACT; HOLCUS LANATUS EXTRACT; ORALGEN; PERENNIAL RYEGRASS EXTRACT; PHLEUM PRATENSE EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ECZEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HAY FEVER; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NASAL PRURITUS; NOSE CONGESTION; OCULAR PRURITUS; ORAL IRRITATION; ORAL PRURITUS; ORAL SWELLING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; RHINITIS; RHINOCONJUNCTIVITIS; RHINORRHEA; SCORING SYSTEM; SNEEZING; STATISTICAL SIGNIFICANCE; SWELLING; SYMPTOM;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; POACEAE; POLLEN; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL;

EID: 34047164409     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.12.651     Document Type: Article

References (31)

1. Di Rienzo V., Pagani A., Parmiani S., Passalacqua G., and Canonica G.W. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 54 (1999) 1110-1113
2. André C., Vatrinet C., Galvain S., Carat F., and Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121 (2000) 229-234
3. Wilson D.R., Torres Lima M., and Durham S.R. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2 (2003) CD002893
4. Olaguibel J.M., and Álvarez Puebla M.J. Efficacy of sublingual allergen vaccination for respiratory allergen in children. Conclusions from one meta-analysis. J Invest Allergol Clin Immunol 15 (2005) 9-16
5. Penagos M., Compalati E., Tarantini F., Baena-Cagnani R., Huerta J., Passalacqua G., et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo controlled, double-blind trials. Ann Allergy Asthma Immunol 97 (2006) 141-148
6. Möller C., Dreborg S., Ferdousi H.A., Halken S., Høst A., Jacobsen L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 109 (2002) 251-256
7. Des Roches A., Paradis L., Menardo J.-L., Bouges S., Daurés J.-P., and Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99 (1997) 450-453
8. Lamberts H., and Woods M. International classification of primary care (1987), Oxford University Press, Oxford
9. Bousquet J., Lockey R.F., and Malling H.-J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 suppl 44 (1998) 1-42
10. Asher M.I., Keil U., Anderson H.R., Beasley R., Crane J., Martinez F., et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 8 (1995) 483-491
11. Juniper E.F., Howland W.C., Roberts N.B., Thompson A.K., and King D.R. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 101 (1998) 163-170
12. Juniper E.F., Guyatt G.H., and Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93 (1994) 413-423
13. Hordijk G.J., Antvelink J.B., and Luwema R.A. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol 26 (1998) 234-240
14. Malling H.-J. Immunotherapy as an effective tool in allergy treatment. Allergy 53 (1998) 461-472
15. Winther L., Malling H.-J., Moseholm L., and Mosbech H. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 55 (2000) 818-826
16. Bufe A., Ziegler-Kirbach E., Stoeckmann E., Heidemann P., Gehlhar K., Holland-Letz T., et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 59 (2004) 498-504
17. Rolinck-Werninghaus C., Wolf H., Liebke C., Baars J.C., Lange J., Kopp M.V., et al. A prospective, randomised, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 59 (2004) 1285-1293
18. Ippoliti F., De Santes W., Volterrani A., Lenti L., Canitano N., Lucacelli S., et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 14 (2003) 216-221
19. Pajno G.B., Vita D., Parmiani S., Caminiti L., La Grutta S., and Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 33 (2003) 1641-1647
20. Bahçeciler N.N., Işik U., Barlan I.B., and Başaran M.M. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 32 (2001) 49-55
21. La Rosa M., Ranno C., André C., Carat F., Tosca M.A., and Canonica G.W. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 104 (1999) 425-432
22. Yuksel H., Tanac R., Gousseinov A., and Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. Invest Allergol Clin Immunol 9 (1999) 305-313
23. Vourdas D., Syrigou E., Potamianou P., Carat F., Batard T., André C., et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 53 (1998) 662-672
24. Hirsch T.H., Sähn M., and Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 8 (1997) 21-27
25. Tari M.G., Mancino M., and Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol 18 (1990) 277-284
26. Bousquet J., Neukirch F., Bousquet P.J., Gehano P., Klossek J.M., Le Gal M., et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117 (2006) 158-162
27. Van Hoecke H., Vastesaeger N., Dewulf L., Sys L., and Van Cauwenberge P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy 61 (2006) 705-711
28. Bousquet J., Van Cauwenberge P., Khaltaev N., and ARIA Workshop Group. World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 (2001) S147-S334
29. Bodtger U., Poulsen L.K., and Malling H.-J. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 33 (2003) 496-500
30. Smith H., White P., Annila I., Poole J., André C., and Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 114 (2004) 831-837
31. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., and Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809